Inhibition of the serine protease HtrA1 by SerpinE2 suggests an extracellular proteolytic pathway in the control of neural crest migration
preprint
OA: closed
Abstract
ABSTRACT We previously showed that SerpinE2 and the serine protease HtrA1 modulate fibroblast growth factor (FGF) signaling in germ layer specification and head-to-tail development of Xenopus embryos. Here we present an extracellular proteolytic mechanism involving this serpin-protease system in the developing neural crest (NC). Knockdown of SerpinE2 by injected antisense morpholino oligonucleotides did not affect the specification of NC progenitors but instead inhibited the migration of NC cells, causing defects in dorsal fin, melanocyte and craniofacial cartilage formation. Similarly, overexpression of the HtrA1 protease impaired NC cell migration and the formation of NC-derived structures. The phenotype of SerpinE2 knockdown was overcome by concomitant downregulation of HtrA1, indicating that SerpinE2 stimulates NC migration by inhibiting endogenous HtrA1 activity. SerpinE2 binds to HtrA1, and the HtrA1 protease triggers degradation of the cell surface proteoglycan Syndecan-4 (Sdc4). Microinjection of Sdc4 mRNA partially rescued NC migration defects induced both by HtrA1 upregulation and SerpinE2 downregulation. These epistatic experiments suggest a proteolytic pathway by a double inhibition mechanism: SerpinE2 ┤HtrA1 protease ┤Syndecan-4 → NC cell migration
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (72)
- doi:10.1242/dev.113886 via crossref
- doi:10.1002/(sici)1097-0177(199611)207:3<281::aid-aja5>3.0.co;2-d via crossref
- doi:10.1016/j.ajog.2008.04.046 via crossref
- doi:10.1016/s0012-1606(03)00277-x via crossref
- doi:10.1167/iovs.09-4853 via crossref
- doi:10.1007/978-3-319-22711-5_11 via crossref
- doi:10.1038/sj.onc.1205911 via crossref
- doi:10.1002/aja.1002030202 via crossref
- doi:10.1006/dbio.1993.1026 via crossref
- doi:10.1158/1541-7786.mcr-09-0473 via crossref
- doi:10.1186/1477-7827-9-106 via crossref
- doi:10.1002/jcb.22121 via crossref
- doi:10.1128/mcb.00035-09 via crossref
- doi:10.1002/jcb.21804 via crossref
- doi:10.1002/dvdy.20217 via crossref
- doi:10.1002/jez.1400720102 via crossref
- doi:10.1038/nrm2720 via crossref
- doi:10.1242/dmm.024661 via crossref
- doi:10.1002/dvg.23107 via crossref
- doi:10.1074/jbc.m500361200 via crossref
- doi:10.1074/jbc.m709299200 via crossref
- doi:10.1016/j.cell.2011.02.013 via crossref
- doi:10.1016/j.ydbio.2022.04.005 via crossref
- doi:10.1016/0092-8674(89)90612-0 via crossref
- doi:10.1016/j.devcel.2007.07.001 via crossref
- doi:10.1371/journal.pone.0167805 via crossref
- doi:10.1038/s41598-019-46599-6 via crossref
- doi:10.3390/cancers13133322 via crossref
- doi:10.1128/mcb.00872-12 via crossref
- doi:10.1002/(sici)1097-0177(200002)217:2<170::aid-dvdy4>3.0.co;2-9 via crossref
- doi:10.1017/cbo9780511897948 via crossref
- doi:10.1002/dvdy.21913 via crossref
- doi:10.18632/oncotarget.26039 via crossref
- doi:10.1016/j.cell.2005.12.018 via crossref
- doi:10.1182/blood-2012-03-415869 via crossref
- doi:10.1111/febs.12174 via crossref
- doi:10.1016/j.gde.2013.02.004 via crossref
- doi:10.1242/dev.017350 via crossref
- doi:10.1016/bs.ctdb.2021.03.002 via crossref
- doi:10.1242/dev.106.4.685 via crossref
- doi:10.1242/dev.040048 via crossref
- doi:10.1016/j.semcdb.2016.08.012 via crossref
- doi:10.1016/j.cell.2016.06.028 via crossref
- doi:10.1074/jbc.m109.028498 via crossref
- doi:10.1016/b978-0-12-385504-6.00005-1 via crossref
- doi:10.1016/j.mod.2006.04.005 via crossref
- doi:10.1016/j.ejcb.2018.06.003 via crossref
- doi:10.1007/s00417-014-2901-2 via crossref
- doi:10.1387/ijdb.052003ep via crossref
- doi:10.1007/978-1-4939-2303-8_8 via crossref
- doi:10.1016/j.ceb.2020.05.001 via crossref
- doi:10.1016/s0092-8674(00)80424-9 via crossref
- doi:10.1038/ng.757 via crossref
- doi:10.1016/0012-1606(87)90463-5 via crossref
- doi:10.1083/jcb.107.2.743 via crossref
- doi:10.1016/j.ydbio.2011.03.010 via crossref
- doi:10.1016/j.semcdb.2022.04.008 via crossref
- doi:10.1016/j.tcb.2020.06.004 via crossref
- doi:10.1038/nature19840 via crossref
- doi:10.1098/rstb.2019.0387 via crossref
- doi:10.1002/jcp.1041380129 via crossref
- doi:10.1002/jez.1400440104 via crossref
- doi:10.1242/dev.078675 via crossref
- doi:10.1146/annurev-genet-120417-031559 via crossref
- doi:10.1038/s41419-019-1882-9 via crossref
- doi:10.1002/dvdy.20071 via crossref
- doi:10.1002/j.1460-2075.1985.tb03793.x via crossref
- doi:10.1038/nature14403 via crossref
- doi:10.1371/journal.pone.0039446 via crossref
- doi:10.1016/s0955-0674(00)00254-4 via crossref
- doi:10.1186/s12915-021-01046-9 via crossref
- doi:10.1016/j.abb.2017.04.004 via crossref
Source provenance
- crossref
- last seen: 2026-06-01T01:00:30.562474+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-08-11T06:58:28.661508+00:00